Mar 2, 2026 04:01PM

Feb 3, 2026 08:33AM

Feb 3, 2026 08:33AM

Aug 7, 2025 04:06PM

Jun 18, 2025 06:38AM

Mar 19, 2025 04:10PM

Mar 17, 2025 04:01PM Quanterix Releases Financial Results for the Fourth Quarter of 2024

Feb 18, 2025 03:41PM

Feb 18, 2025 03:40PM

Jun 12, 2024 07:47AM

Jun 11, 2024 07:54AM

May 7, 2024 04:00PM

Mar 21, 2024 05:30PM

Mar 4, 2024 09:01AM Quanterix (QTRX) Granted FDA Breakthrough Device Designation for p-Tau 217 Test

Mar 4, 2024 09:00AM

Oct 24, 2023 04:30PM

Aug 7, 2023 05:13PM

Jul 6, 2023 05:37PM

May 9, 2023 04:00PM

Apr 25, 2023 04:33PM

Apr 25, 2023 04:30PM FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials

Mar 6, 2023 08:09AM

Jan 9, 2023 08:30AM

Dec 5, 2022 04:36PM

Nov 8, 2022 04:00PM

Jul 11, 2022 08:00AM

Apr 22, 2022 08:30AM

Apr 22, 2022 08:30AM Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis

Mar 1, 2022 07:32AM

Mar 1, 2022 07:30AM

Mar 1, 2022 07:30AM

Jan 13, 2022 07:32AM

Jan 13, 2022 07:30AM

Nov 17, 2021 04:15PM

Nov 16, 2021 09:20AM Quanterix’ Simoa® Technology Powers Advances in Alzheimer’s Disease Research Presented at 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Nov 4, 2021 04:01PM

Oct 12, 2021 09:29AM

Oct 12, 2021 06:08AM

Oct 11, 2021 06:03PM

Oct 11, 2021 05:44PM

Oct 11, 2021 04:06PM

Oct 11, 2021 04:05PM Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181 Assay for Alzheimer’s Disease

Sep 20, 2021 08:26AM

Sep 13, 2021 05:44PM

Sep 13, 2021 05:42PM

Aug 5, 2021 04:18PM

May 5, 2021 04:01PM

Mar 26, 2021 06:48AM

Mar 26, 2021 06:47AM Quanterix’ Simoa Technology Demonstrates Advancements in COVID-19 Research through Viral Antigen Measurements in Blood and Saliva Samples

Mar 2, 2021 04:03PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All